PVLA

Palvella Therapeutics, Inc. $146.15 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
+1.7%
Next 1 month
+4.0%
Seasonality
Weak window historically
Next 30 days (to Nov 30): -4.6% median, 40% of the last 10 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 55
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.11%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.70 +4.2% · Seasonal tilt (10y) -0.3%
$30M/day volume 83% volatility +94% 1-year -81% from ATH
52-week range · 83% of the way up · -9% from the high
$71.55$161.38

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS est. -1.73.

Biggest pop
+12.6%
Biggest drop
-13.0%

Standard deviation of the close-to-close move over the last 7 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-04 miss -1.15 -1.52 -32.0% -3.9% +8.0% +9.6%
2026-05-07 miss -0.93 -1.20 -29.3% -0.9% -13.0% -8.6%
2026-03-31 miss -0.91 -1.08 -18.6% +4.4% +12.6% +11.3%
2025-11-10 miss -0.85 -1.03 -21.3% -5.2% -3.0% +3.3%
2025-08-14 miss -0.77 -0.86 -12.0% -1.8% +3.3% +14.9%
2025-05-15 beat -1.32 -0.74 +43.9% -2.8% -0.4% +1.9%
2025-03-31 miss -0.60 -5.37 -798.7% +2.4% -0.4% -28.6%

Not investment advice.